Commonly reported side effects of mitoxantrone include: upper respiratory tract infection, urinary tract infection, fungal infection, fungal skin infection, infection, sepsis, alopecia, amenorrhea, cardiac arrhythmia, constipation, diarrhea, ecg abnormality, gastrointestinal hemorrhage, increased gamma-glutamyl transferase, leukopenia, menstrual disease, nausea, stomatitis, urine abnormality, abdominal pain, aphthous stomatitis, asthenia, burning sensation of gastrointestinal tract, cough, decreased hemoglobin, decreased white blood cell count, dyspnea, edema, epigastric pain, fatigue, fever, hematuria, hyperglycemia, hypocalcemia, hypokalemia, increased serum glucose, lymphocytopenia, mucositis, pharyngitis, rhinitis, stomach pain, thrombocytopenia, vomiting, weight gain, abnormal absolute neutrophil count, anorexia, malaise, and nail bed changes.
Other side effects include: pneumonia, renal failure, seizure, skin infection, anemia, back pain, granulocytopenia, headache, sinusitis, anxiety, arthralgia, conjunctivitis, depression, dyspepsia, hemorrhage, hypermenorrhea, hypertension, hyponatremia, impotence, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, ischemic heart disease, myalgia, pain, petechia, proteinuria, sterility, bruise, chills, diaphoresis, and ecchymoses.
See below for a comprehensive list of adverse effects.
If any of the following side effects occur while taking mitoxantrone, check with your doctor or nurse immediately:
Very common (10% or more): Platelets low (up to 33%), leukopenia (up to 19%), white blood cells low (up to 100%)Common (1% to 10%): Myelosuppression (especially leucopenia)Uncommon (0.
1% to 1%): Thrombocytopenia, anemiaFrequency not reported: Bone marrow depression
Frequency not reported: Acute myeloid leukemia (AML), acute myelodysplastic syndrome (AMS)
Very common (10% or more): Nausea (up to 76%), stomatitis (up to 19%), diarrhea (up to 16%), gastralgia/stomach burn/epigastric pain (up to 14%), constipation (up to 10%), aphthosis (up to 10%)Common (1% to 10%): VomitingUncommon (0.
1% to 1%): Anorexia, GI bleeding, abdominal pain, altered tasteFrequency not reported: Mucositis, vomiting
Very common (10% or more): Arrhythmia (up to 18%), ECG abnormal (up to 11%)Uncommon (0.
1% to 1%): HypotensionFrequency not reported: Acute arrhythmias, transient ECG alterations, reduced left ventricular output, cardiac insufficiency, congestive heart failure (CHF)
Uncommon (0.
1% to 1%): Phlebitis, erythema, swelling, pain, burning and/or blue discoloration of the skinRare (less than 0.
1%): Tissue necrosis (following extravasation)
Common (1% to 10%): HeadacheUncommon (0.
1% to 1%): Somnolence, mild paresthesia
Uncommon (0.
1% to 1%): Anaphylaxis
Very common (10% or more): Reversible alopecia (up to 61%)Uncommon (0.
1% to 1%): Urticaria, rash, nail pigmentation, onycholysis
Uncommon (0.
1% to 1%): Elevated serum creatinine, elevated blood urea nitrogenFrequency not reported: Renal failure
Very common (10% or more): Gamma-glutamyl transpeptidase increased (up to 15%)Common (1% to 10%): Alanine aminotransferase (ALT or SGPT) increased, aspartate aminotransferase (AST or SGOT) increased, granulocytopenia, anemiaUncommon (0.
1% to 1%): Increased liver enzyme levels, elevated bilirubin levels
Very common (10% or more): Asthenia (up to 24%)Uncommon (0.
1% to 1%): Fever, fatigue, weakness
Very common (10% or more): Menstrual disorder (including amenorrhea) (up to 61%), urinary tract infection (up to 32%), abnormal urine (up to 11%)Common (1% to 10%): MenorrhagiaFrequency not reported: Blue-green coloration of the urine 1 to 2 days after administration
Frequency not reported: Amenorrhea
Very common (10% or more): Infection (e.
g.
, tonsillitis, enteritis, urinary tract infection, viral infection, endometritis) (up to 85%), cutaneous mycosis (up to 10%)
Very common (10% or more): Glucose high (up to 10%), potassium low (up to 10%)Common (1% to 10%): Back painRare (less than 0.
1%): Tumor lysis syndrome (characterized by hyperuricemia, hypercalcemia, hyperphosphatasemia, hypocalcemia)
Uncommon (0.
1% to 1%): Reversible blue coloration of the scleraFrequency not reported: Lethargy, fatigue, seizures
Frequency not reported: Depression
Very common (10% or more): Upper respiratory tract infection (up to 53%), pharyngitis/throat infection (up to 19%), rhinitis (up to 10%)Common (1% to 10%): SinusitisUncommon (0.
1% to 1%): Dyspnea, pneumonitis
Black, tarry stools
bladder pain
bloody or cloudy urine
cough or shortness of breath
difficult, burning, or painful urination
dizziness
fainting
fast, slow, or irregular heartbeat
frequent urge to urinate
lower back or side pain
pale skin
stomach pain
swelling or inflammation of the mouth
troubled breathing with exertion
ulcers, sores, or white spots in the mouth
unusual bleeding or bruising
unusual tiredness or weakness
Blood in the urine or stools
decrease in urination
fever or chills
pinpoint red spots on the skin
seizures
sore, red eyes
swelling of the feet and lower legs
yellow eyes or skin
Blue skin at the place of injection
pain or redness at the place of injection
skin rash
Absent, missed, or irregular menstrual periods
back pain
body aches or pains
congestion
constipation
diarrhea
dryness or soreness of the throat
hair loss
headache
longer or heavier menstrual periods
nausea or vomiting
oral bleeding
pain or tenderness around the eyes and cheekbones
runny nose
sneezing
stopping of menstrual bleeding
stuffy nose
tender, swollen glands in the neck
thinning of the hair